Case Report: Use of Liposomal Amphotericin B in Low Doses in Patients With Visceral Leishmaniasis

Background: No consensus has been reached regarding the optimal therapy for visceral leishmaniasis (VL), which affects ~12 million people worldwide.Case Presentation: This report described four cases of VL encountered in the First Affiliated Hospital of Xi'an Jiaotong University between October...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Danfeng Ren, Wenya Cao, Xiaojing Liu, Qunying Han, Wanhu Fan, Guoliang Li, Han Xia, Xi Zhang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/70ab15800e874ed78577a2321e14521b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!